JW Leavenworth, ME Pauza - Cellular Immunology, 2009 - Elsevier Islet specific CD4 cells expressing inhibitory receptors may be a useful
therapeutic tool for treating type 1 diabetes (T1D). Engagement of transgenic
Ly49A inhibits CD4 cell activation and delays onset of T1D in mice. ... Related articles